1-15 of 15
LDL-C Management in Focus: A Clinical Dialogue Between Experts
Medical Industry FeatureLDL-C Management in Focus: A Clinical Dialogue Between Experts
Jaime Burkle, MD, FACC, FNLA
M. Chadi Alraies, MD, FACC, FSCAI
Aiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Medical Industry FeatureAiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Andrew Freeman, MD, FACC, FACP
Lily Dastmalchi, DO
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Jennifer Caudle, DO, FACOFP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
- advertisement
Quick Takes in ATTR-CM: Symptoms and Comorbidities
Medical Industry FeatureQuick Takes in ATTR-CM: Symptoms and Comorbidities
Joshua Mitchell, MD, FACC
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Martha Gulati, MD, MS, FACC, FAHA
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Brian P. McDonough, MD, FAAFP
Javier Morales, MD, FACP, FACE
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Groundbreaking AI Models Transform Cardiovascular Diagnosis
Medical Industry FeatureGroundbreaking AI Models Transform Cardiovascular Diagnosis
Pierre Elias, M.D.
How GLP-1s Provide New Options to Manage Heart Disease
Medical Industry FeatureHow GLP-1s Provide New Options to Manage Heart Disease
David Majure, M.D., MPH
- advertisement
A Landmark Surgery That Saved Three Children With One Heart
Medical Industry FeatureA Landmark Surgery That Saved Three Children With One Heart
Andrew Goldstone, M.D., Ph.D.
Advancing Cardiology and Heart Surgery Through a History of Collaboration
Medical Industry FeatureAdvancing Cardiology and Heart Surgery Through a History of Collaboration
Craig Smith, M.D.
Keys to Helping Overcome the Growing Prevalence of Peripheral Artery Disease
Medical Industry FeatureKeys to Helping Overcome the Growing Prevalence of Peripheral Artery Disease
